✦ LIBER ✦

39 Chemoradiation therapy for non-small cell lung cancer

✍ Scribed by Bando, Hiroyasu; Sone, Saburou

Book ID: 122539519
Publisher: Elsevier Science
Year: 2003
Tongue: English
Weight: 177 KB
Volume: 41
Category: Article
ISSN: 0169-5002
DOI: 10.1016/S0169-5002(03)92730-9

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Induction concurrent chemoradiation ther

Induction concurrent chemoradiation therapy for invading apical non-small cell lung cancer

✍ Shinichiro Miyoshi; Keiji Iuchi; Kenji Nakamura; Katsuhiro Nakagawa; Hajime Maed 📂 Article 📅 2004 🏛 Springer Japan 🌐 Japanese ⚖ 484 KB

Outcome of Concurrent Chemoradiation The

Outcome of Concurrent Chemoradiation Therapy for Stage III Non-Small Cell Lung Cancer

✍ Liu, L.; Ji, Z.; Cao, J.; Wang, J.; Hui, Z.; Liang, J.; Wang, X.; Lv, J.; Wang, 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 54 KB

Chemoradiation for Unresectable Stage II

Chemoradiation for Unresectable Stage III Non-Small Cell Lung Cancer

✍ Katharine A.R. Price; Christopher G. Azzoli; Laurie E. Gaspar 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 184 KB

Pneumonectomy After Chemoradiation Thera

Pneumonectomy After Chemoradiation Therapy for Non-Small Cell Lung Cancer: Does “Side” Really Matter?

✍ Anthony W. Kim; L. Penfield Faber; William H. Warren; Sanjib Basu; Sean C. Wight 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 262 KB

353 Combined chemoradiation therapy for

353 Combined chemoradiation therapy for locally advanced resectable non small cell lung cancer (NSCLC)

✍ Douillard, J.Y.; Bardet, E.; Le Groumellec, A.; Maury, B.; Bennouna, J.; Morel, 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 150 KB

Simultaneous chemoradiation in advanced

Simultaneous chemoradiation in advanced non-small cell lung cancer

✍ Julianna Pisch; Stephen Malamud; James Harvey; Edward J. Beattie 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 558 KB

We designed our study to evaluate the safety and efficacy of simultaneous chemoradiation therapy in an accelerated, twice-a-day schedule to improve local control and survival in advanced lung cancer patients. Forty-one patients were entered into the study. Twenty-three had stage IIIB and 18 had stag